At-home OCT enables daily monitoring of patients with neovasular age-related macular degeneration (AMD) and other patients that need a lot of follow-ups.
With host Carey Powers, Dr. Anat Loewenstein dives into at-home OCT innovation, application, and adoption.
Dr. Loewenstein is Head of the Department of Ophthalmology and Vice Dean at Tel Aviv Medical Center. She’s also a fellowship-trained vitreoretinal surgeon and has been heavily involved in research related to early AMD detection.
Why all the fuss about at-home OCT? An at-home monitoring solution will potentially lessen the number of appointments for patients who don’t need them. More-frequent monitoring could also help catch disease changes sooner so doctors can facilitate treatment asap.
Listen to the podcast today to discover:
- How at-home OCT works and the role artificial intelligence (AI) plays in image analysis.
- The patient experience when using at-home OCT.
- How disease activity alerts are delivered from the at-home device to the physician.
- Once a physician receives an alert, steps to take to get the patient into the clinic right away.
- The status of products closest to FDA approval, such as Notal Home OCT from Notal Vision.
- Dr. Loewenstein’s thoughts on the global health implications of at-home OCT.
[Listen Now]
Resources
Anat Loewenstein: linkedin.com/in/anat-loewenstein-b48a595
Carey Powers: ois.net/carey-powers